博拓生物股价涨5.01%，广发基金旗下1只基金重仓，持有423.6万股浮盈赚取851.44万元

Group 1 - The core viewpoint of the news is that Botao Bio has seen a stock price increase of 5.01%, reaching 42.14 CNY per share, with a total market capitalization of 6.293 billion CNY [1] - Botao Bio, established on November 28, 2008, specializes in the research, production, and sales of POCT diagnostic reagents, with 100% of its revenue derived from POCT products [1] - The trading volume for Botao Bio was 30.6043 million CNY, with a turnover rate of 0.49% [1] Group 2 - According to data, Guangfa Fund's Guangfa Value Core Mixed A Fund (010377) increased its holdings in Botao Bio by 1.5021 million shares in the second quarter, now holding 4.236 million shares, which is 2.84% of the circulating shares [2] - The fund has achieved a year-to-date return of 55.31%, ranking 428 out of 8162 in its category, and a one-year return of 62.05%, ranking 296 out of 8024 [2] - The fund manager, Wu Yuanyi, has a tenure of 5 years and 23 days, with the fund's total asset size at 20.478 billion CNY [2] Group 3 - The Guangfa Value Core Mixed A Fund (010377) holds Botao Bio as its eighth-largest position, with 4.236 million shares representing 2.75% of the fund's net value [3] - The estimated floating profit from this position is approximately 8.5144 million CNY [3]